Status:
COMPLETED
Effectiveness of Adaptive Servoventilation (ASV) in Patients With Central Sleep Apnea Due to Chronic Opioid Use
Lead Sponsor:
ResMed
Conditions:
Obstructive Sleep Apnea
Central Sleep Apnea (Diagnosis)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Prospective, randomized, blinded, cross-over study assessing the effectiveness of adaptive servo-ventilation (ASV) in treating patients who have obstructive sleep apnea (OSA) complicated by central sl...
Detailed Description
The trial seeks to determine the efficacy and patient comfort of ASV and bi-level positive airway pressure (PAP) modes for the treatment of obstructive sleep apnea (OSA), complicated by CSA secondary ...
Eligibility Criteria
Inclusion
- At least 18 years old
- Taking opioid medications for at least 6 months. Opioid medications include but are not limited to: oxycodone, fentanyl, methadone, levorphanol, hydromorphone, and morphine
- Using bi-level PAP for at least 30 days
Exclusion
- Primary heart or lung disease, for example: chronic obstructive pulmonary disease, pulmonary fibrosis, severe heart failure, uncorrected congenital heart disease, pulmonary hypertension
- Primary neurologic disease, for example: neuromuscular disease, previous stroke or cognitive impairment
- Narcolepsy
- Acute upper respiratory tract infection
- Pregnant
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT01462084
Start Date
September 1 2011
End Date
December 1 2012
Last Update
April 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Center for Human Sleep Research
Redwood City, California, United States, 94603